Chloe Ramirez
A 5-way equine vaccine is an intramuscular vaccination that protects horses from five different viruses. The vaccine is typically administered to horses that are at least six months old and sometimes older. The Prestige 5 Equine Vaccine, for example, protects against Eastern and Western Encephalomyelitis viruses, Equine Influenza Virus, Equine Herpesvirus types 1 and 4, and Tetanus. The Fluvac Innovator 5 vaccine, on the other hand, protects against Eastern and Western Encephalomyelitis, Equine Rhinopneumonitis, Equine Influenza, and Tetanus.
| Characteristics | Values |
|---|---|
| Brand Name | Prestige 5, Fluvac Innovator 5 |
| Vaccination Age | 6 months or older, 10 months or older |
| Vaccines Against | Eastern and Western Encephalomyelitis viruses, Equine Influenza Virus, Equine Herpesvirus types 1 and 4, Tetanus, West Nile Virus |
| Dosage | 1 ml |
| Administration | Intramuscular injection |
| Repeat Dose | After 3-4 weeks |
| Revaccination | Annually |
| Side Effects | Local reactions at injection site, anaphylactoid reactions |
| Antibiotic | Gentamicin |
| Preservative | Thimerosal |
Explore related products
What You'll Learn
Eastern and Western Encephalomyelitis viruses
Equine Encephalomyelitis viruses, also known as arboviruses, are arthropod-borne viruses transmitted by mosquitoes. The Eastern and Western Encephalomyelitis viruses (EEE and WEE) are two of the three neurotropic Alphaviruses, along with Venezuelan equine encephalitis viruses (VEEV). These viruses can cause febrile illness in both equines and humans, which may progress to encephalitis.
Vaccination is crucial in combating these infectious diseases. The Prestige 5 Equine Vaccine by Merck Animal Health is one such vaccine that protects against EEE and WEE. It is recommended for horses 6 months of age or older and is administered intramuscularly. The vaccine is effective for 6 months and helps protect against respiratory diseases.
The Fluvac Innovator 5 by Santa Cruz Animal Health is another vaccine that offers protection against EEE and WEE. It is recommended for horses and foals over 10 months old. This vaccine is also administered intramuscularly, with a second dose in 3-4 weeks, and an annual booster dose.
It is important to note that these vaccines have not been tested in pregnant animals, and specific guidelines are provided for vaccinating pregnant mares. Additionally, there are high-risk situations where consultation with a veterinarian is necessary to determine the appropriate vaccination schedule.
While vaccines are available for EEE and WEE, there are currently no licensed treatments or vaccines for humans infected with these viruses.
Explore related products
Equine Influenza virus
Equine Influenza (EI) is a highly contagious respiratory disease that affects horses, donkeys, mules, and other equidae. It is caused by two subtypes of the influenza A virus, H7N7 and H3N8, which are related to but distinct from influenza viruses in other species. H7N7 is thought to be extinct, while H3N8 is widespread worldwide and further divided into sublineages, with the Florida sublineage currently circulating. The European lineage is not currently recognised as a cause of infection in horses.
The disease has been recorded throughout history, and when horses were the primary draft animals, EI outbreaks had a devastating impact on the economy. Today, EI outbreaks continue to have severe economic consequences for the equine industry, particularly when they occur at events where large groups of horses gather, such as races and shows. Increased transportation of horses across state lines and between countries also facilitates the spread of the virus.
EI is characterised by a high rate of transmission among horses and a short incubation period of 1-3 days. The virus is transmitted primarily through inhalation of infective respiratory secretions from coughing horses, with coughing horses being able to spread the virus up to 150 feet. Indirect transmission can also occur via fomites, such as clothing, hands, shared water buckets, brushes, and tack.
The clinical outcome after viral exposure depends on the immune status of the horse. In fully susceptible animals, clinical signs include fever, a harsh dry cough, nasal discharge, lethargy, loss of appetite, muscle pain, and weakness. These signs generally resolve within a few days, but complications due to secondary infections, such as bacterial pneumonia, are common. While EI is rarely fatal, death can occur due to pneumonia, especially in foals.
Vaccination against EI is practised in most countries, and vaccines aim to include the most updated flu strains available. However, due to the constant evolution of the virus and the difficulty in matching vaccine strains to circulating strains, vaccination does not always prevent infection. Nonetheless, vaccination can reduce disease severity and speed up recovery times.
Explore related products
Equine Herpesvirus types 1 and 4
Equine herpesviruses 1 (EHV-1) and 4 (EHV-4) are two of the most significant subtypes of the herpesvirus that affect horses worldwide. They are endemic in horse populations, and both viruses can establish a lifelong presence in the infected host after the primary infection. EHV-1 and EHV-4 share a high degree of genetic and antigenic similarity, but they differ in host range and pathogenicity.
EHV-1 has a broader host range and can infect at least three distinct cell types in horses. It is highly contagious and usually transmitted by direct contact, primarily through infected nasal discharge. It can also be transmitted through aerosol or contaminated feed, water, and equipment. In addition to respiratory disease, EHV-1 can cause abortions, neonatal death, and equine herpesvirus myeloencephalopathy (EHM). It is also associated with other diseases, including late gestation abortion storms and increasing morbidity and mortality in documented outbreaks since 2000. The USDA-APHIS has designated EHV-1 as an emerging disease, and it is reportable in many states within the US.
On the other hand, EHV-4 infection is primarily limited to horses and causes respiratory disease. While EHV-4 can cause respiratory disease outbreaks, it only rarely results in abortion in pregnant mares. Most of these outbreaks in weanlings are caused by strains of EHV-4.
Vaccination is recommended to prevent EHV-1 and EHV-4 infections. The Prestige 5 Equine Vaccine, for example, has been shown to be effective for the vaccination of healthy horses 6 months of age or older against EHV-1 and EHV-4. Fluvac Innovator 5 is another vaccine that offers protection against EHV-1 and EHV-4 in horses and foals over 10 months old.
Explore related products
Tetanus
The tetanus toxoid vaccine contains a modified form of the tetanus toxin that stimulates the horse's immune system to produce antibodies against the disease. These antibodies protect the horse by neutralizing the toxin produced by the bacteria, preventing it from causing harm.
The 5-way equine vaccine provides protection against tetanus, along with other common equine diseases such as Eastern and Western Encephalomyelitis, Equine Influenza, and Equine Herpesvirus. This combination vaccine offers convenience and helps ensure the horse is protected against multiple diseases with a single injection.
It is important to note that the 5-way vaccine may not be suitable for all horses, and some horses may experience local or systemic reactions after vaccination. It is always advisable to consult with a veterinarian before administering any vaccine to ensure it is appropriate for the individual horse's health status and vaccination history.
The Prestige 5 Equine Vaccine by Merck Animal Health and the Fluvac Innovator® 5 by Santa Cruz Animal Health are two examples of 5-way equine vaccines that offer protection against tetanus. These vaccines are recommended for healthy horses over a certain age, typically six months or older, and are administered intramuscularly.
Explore related products
West Nile Virus
The Prestige 5+WNV vaccine by Merck Animal Health is designed to vaccinate healthy horses 6 months of age or older against WNV, in addition to Eastern and Western encephalomyelitis viruses, equine herpesviruses types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8, and tetanus toxoid. The duration of immunity has been shown to be 6 months for the equine influenza virus, and the vaccine has been shown to decrease virus shedding of the influenza and EHV-1, as well as reduce encephalitis and viremia caused by WNV.
The Fluvac Innovator 5 vaccine by Santa Cruz Animal Health does not include the WNV vaccine. However, one customer mentions that they also vaccinate their horses for WNV, indicating that it is an additional vaccine.
It is important to note that the 5-way vaccine combines vaccines for five different viruses, which may overwhelm a horse's immune system. Research has shown that a horse's immune system produces a higher antibody level after an individual vaccine rather than a combination vaccine. Therefore, it is recommended to consult a veterinarian before administering any vaccine to your horse.
Frequently asked questions
A 5-way equine vaccine is a vaccine that protects horses from five different viruses.
The five viruses that the vaccine protects against are: Equine Encephalomyelitis (EEE, WEE), Equine Influenza (EIV), Equine Herpesvirus (EHV-1, EHV-4), and Tetanus.
The benefits of a 5-way vaccine are that it provides broad protection against multiple viruses in a single dose, which can be more convenient and cost-effective than administering multiple individual vaccines.
